‘Europe Has To Make Up Its Mind’ – Medicines For Europe’s Sieger On The Path Ahead

5 August 2025

The president of Medicines for Europe talks about what the […]

European Industry Calls For Support As It Juggles Multiple Challenges

5 July 2025

At Medicines for Europe’s Legal and Annual Conferences in Brussels […]

Biosimilar medicines: the intersection of access, affordability, and innovation

3 February 2025

Director of Biosimilar Policy & Science at Medicines for Europe, […]

Elisabeth Stampa: ‘Many drugs that used to be produced in Europe are now manufactured in Asia. This makes us vulnerable to shortages’

2 September 2024

The president of Medicines for Europe considers that the supply […]

The enormous and unknown healing power of old medicines (ES)

11 March 2024

The legislative reform being prepared by the EU plans to […]

Health Policy Watch: Forum Discusses High Drug Prices in Wealthy Countries and Access to Medicines in Conflicts

12 February 2024

Adrian van den Hoven, chair of the International Generic and […]

New pricing models for generic medicines to ensure long-term sustainable competition in Europe

10 October 2023

Background: Price erosion of generic medicines over time as a […]

(IT) Healthcare Policy – Autonomia strategica nel Pharma. Serve un’azione politica

26 June 2023

Bulgarian National Television – The EU is preparing the most extensive changes in medical legislation in 20 years

4 May 2023

Open

Euronews – New EU medicine rules, articifical intelligence and fast fashion

4 May 2023

Adrian Van Der Hoven joins panelists elaborating on the EU […]